These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 34719501)
41. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models. Shi C; Viccaro K; Lee HG; Shah K J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684 [TBL] [Abstract][Full Text] [Related]
42. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461 [TBL] [Abstract][Full Text] [Related]
43. Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease. Hanzel CE; Pichet-Binette A; Pimentel LS; Iulita MF; Allard S; Ducatenzeiler A; Do Carmo S; Cuello AC Neurobiol Aging; 2014 Oct; 35(10):2249-62. PubMed ID: 24831823 [TBL] [Abstract][Full Text] [Related]
44. Astrocytic gap junctional communication is reduced in amyloid-β-treated cultured astrocytes, but not in Alzheimer's disease transgenic mice. Cruz NF; Ball KK; Dienel GA ASN Neuro; 2010 Aug; 2(4):e00041. PubMed ID: 20730033 [TBL] [Abstract][Full Text] [Related]
45. Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease. Edwards MM; Rodríguez JJ; Gutierrez-Lanza R; Yates J; Verkhratsky A; Lutty GA Exp Eye Res; 2014 Oct; 127():252-60. PubMed ID: 25149907 [TBL] [Abstract][Full Text] [Related]
46. Astrocytes as a Therapeutic Target in Alzheimer's Disease-Comprehensive Review and Recent Developments. Rodríguez-Giraldo M; González-Reyes RE; Ramírez-Guerrero S; Bonilla-Trilleras CE; Guardo-Maya S; Nava-Mesa MO Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362415 [TBL] [Abstract][Full Text] [Related]
48. Quantitative expression analysis of APP pathway and tau phosphorylation-related genes in the ICV STZ-induced non-human primate model of sporadic Alzheimer's disease. Park SJ; Kim YH; Nam GH; Choe SH; Lee SR; Kim SU; Kim JS; Sim BW; Song BS; Jeong KJ; Lee Y; Park YI; Lee KM; Huh JW; Chang KT Int J Mol Sci; 2015 Jan; 16(2):2386-402. PubMed ID: 25622254 [TBL] [Abstract][Full Text] [Related]
50. Early Activation of Astrocytes does not Affect Amyloid Plaque Load in an Animal Model of Alzheimer's Disease. Wang D; Zhang X; Wang M; Zhou D; Pan H; Shu Q; Sun B Neurosci Bull; 2018 Dec; 34(6):912-920. PubMed ID: 30032411 [TBL] [Abstract][Full Text] [Related]
51. Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions. Lim D; Tapella L; Dematteis G; Talmon M; Genazzani AA Neurochem Res; 2023 Apr; 48(4):1077-1090. PubMed ID: 36083398 [TBL] [Abstract][Full Text] [Related]
52. Astrocytes from old Alzheimer's disease mice are impaired in Aβ uptake and in neuroprotection. Iram T; Trudler D; Kain D; Kanner S; Galron R; Vassar R; Barzilai A; Blinder P; Fishelson Z; Frenkel D Neurobiol Dis; 2016 Dec; 96():84-94. PubMed ID: 27544484 [TBL] [Abstract][Full Text] [Related]
53. Clusterin secreted from astrocyte promotes excitatory synaptic transmission and ameliorates Alzheimer's disease neuropathology. Chen F; Swartzlander DB; Ghosh A; Fryer JD; Wang B; Zheng H Mol Neurodegener; 2021 Jan; 16(1):5. PubMed ID: 33517893 [TBL] [Abstract][Full Text] [Related]
54. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease. Ceyzériat K; Ben Haim L; Denizot A; Pommier D; Matos M; Guillemaud O; Palomares MA; Abjean L; Petit F; Gipchtein P; Gaillard MC; Guillermier M; Bernier S; Gaudin M; Aurégan G; Joséphine C; Déchamps N; Veran J; Langlais V; Cambon K; Bemelmans AP; Baijer J; Bonvento G; Dhenain M; Deleuze JF; Oliet SHR; Brouillet E; Hantraye P; Carrillo-de Sauvage MA; Olaso R; Panatier A; Escartin C Acta Neuropathol Commun; 2018 Oct; 6(1):104. PubMed ID: 30322407 [TBL] [Abstract][Full Text] [Related]
55. Astrocytes as Neuroimmunocytes in Alzheimer's Disease: A Biochemical Tool in the Neuron-Glia Crosstalk along the Pathogenetic Pathways. Stanca S; Rossetti M; Bongioanni P Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762184 [TBL] [Abstract][Full Text] [Related]
56. Role of Cdk5 in Amyloid-beta Pathology of Alzheimer's Disease. Lu TT; Wan C; Yang W; Cai Z Curr Alzheimer Res; 2019; 16(13):1206-1215. PubMed ID: 31820699 [TBL] [Abstract][Full Text] [Related]
58. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease. Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615 [TBL] [Abstract][Full Text] [Related]
59. Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. Li C; Zhao R; Gao K; Wei Z; Yin MY; Lau LT; Chui D; Yu AC Curr Alzheimer Res; 2011 Feb; 8(1):67-80. PubMed ID: 21143158 [TBL] [Abstract][Full Text] [Related]
60. Changes in Astroglial Water Flow in the Pre-amyloid Phase of the STZ Model of AD Dementia. Gayger-Dias V; Menezes L; Da Silva VF; Stiborski A; Silva ACR; Sobottka TM; Quines-Silva VC; Pakulski-Souto B; Bobermin LD; Quincozes-Santos A; Leite MC; Gonçalves CA Neurochem Res; 2024 Jul; 49(7):1851-1862. PubMed ID: 38733521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]